Abstract:The clinical application of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is controversial. Thus, we conducted a systemic review and meta-analysis of studies comparing ALPPS to conventional two-stage hepatectomy (TSH). This review aims at summarizing and assessing studies on this topic, and using meta-analysis to provide data support regarding the feasibility, safety and oncological efficacy of ALPPS by comparing with conventional TSH. Articles comparing ALPPS with TSH were identified by searching Medline, Embase and Cochrane library, using pre-specified criteria. Newcastle-Ottawa scale was used for quality evaluation. Chi's test was used for heterogeneity exploration among eligible studies. Random and fixed effect models were used to synthesize the outcomes regarding feasibility, safety and oncological efficacy. A total of 6 studies were eligible for systemic review and meta-analysis, involving 502 patients (118 in ALPPS group, 384 in TSH group). Patients underwent ALPPS experienced more overall morbidities and major morbidities (Clavien-Dindo >= IIIa) than patients received TSH did (58% vs. 42.8%, P = 0.04; and 23.4% vs. 15.3%, P = 0.002). R0/R1 resection rates were 86.4% and 71.5% in ALPPS and TSH groups, respectively (P = 0.014). One study reported similar 1-year recurrence free survival (RFS) in both groups. While another study including only patients with colorectal liver metastases observed similar 1-year overall survival in both groups, but higher 1-year RFS in TSH group. Our systemic review suggests that ALPPS induces faster future liver remnant (FLR) hypertrophy, larger FLR increase, and achieves higher completion rate of major hepatectomy than TSH does. Even though mortality rate is similar in these two surgical techniques, overall and major complication rates are higher in ALPPS group. The initial oncological efficacy of ALPPS seems to be encouraging. Yet, R0 status should be paid more attention to in future studies. Controlled trials with extreme caution and carefully selected patients are needed to further assess the advantages and disadvantages of ALPPS.

Comparison Of Feasibility, Safety And Oncological Efficacy Of Associating Liver Partition And Portal Vein Ligation For Staged Hepatectomy (Alpps) With Conventional Two-Stage Hepatectomy (Tsh): A Systemic Review And Meta-Analysis

Perioperative Outcomes Comparing Laparoscopic with Open Repeat Liver Resection for Post-Hepatectomy Recurrent Liver Cancer: A Systematic Review and Meta-Analysis

Laparoscopic Versus Open Surgery for Hepatocellular Carcinoma: A Meta-Analysis of High-Quality Case-Matched Studies

Conventional Two-Stage Hepatectomy or Associating Liver Partitioning and Portal Vein Ligation for Staged Hepatectomy for Colorectal Liver Metastases? A Systematic Review and Meta-Analysis

Associating Liver Partition And Portal Vein Ligation Versus 2-Stage Hepatectomy A Meta-Analysis

A Systematic Review and Meta-Analysis of ALPPS Versus Two-Stage Hepatectomy (TSH)

Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis

[Ten-Year Retrospect of ALPPS in the Treatment of Hepatocellular Carcinoma:An Eternal Concept with Cautious Technologic Choice].

Totally laparoscopic ALPPS for primary liver cancer complicated with cirrhosis----application of ;round-the-liver ligation to replace parenchymal transection

Associating liver partition and portal vein ligation for staged hepatectomy for HCC with liver cirrhosis:A report of 1 case

Completely Laparoscopic Alpps Using Round-The-Liver Ligation To Replace Parenchymal Transection For A Patient With Multiple Right Liver Cancers Complicated With Liver Cirrhosis (Vol 24, Pg 883, 2014)

Modified Procedures for ALPPS Based on a Risk-Reduced Strategy: Paralleled Clinical Evaluation at Multiple Institutions

ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)

Associating liver partition and portal vein ligation for staged hepatectomy: From technical evolution to oncological benefit

Clinical evaluation of modified ALPPS procedures based on risk-reduced strategy for staged hepatectomy

Promising Results of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Perihilar Cholangiocarcinoma in a Systematic Review and Single-Arm Meta-Analysis

Comparison of Clinical Efficacy Between LAPS and ALPPS in the Treatment of Hepatitis B Virus-related Hepatocellular Carcinoma

Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study

The role of associating liver partition and portal vein ligation for staged hepatectomy in unresectable hepatitis B virus-related hepatocellular carcinoma

Evolution of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy: Simpler, Safer and Equally Effective Methods

Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 Patients.